tiprankstipranks
Trending News
More News >
Lotus Pharmaceuticals (LTUS)
:LTUS
US Market

Lotus Pharmaceuticals (LTUS) Income Statement

Compare
4 Followers

Lotus Pharmaceuticals Income Statement

Last quarter (Q2 2024), Lotus Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Lotus Pharmaceuticals's net income was $-2.50K. See Lotus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 18.81K$ 21.11K$ 30.41K$ 6.28K$ -21.83K
Depreciation and Amortization
$ 167.90K$ 228.49K$ 236.56K$ 206.30K$ 171.86K
EBITDA
$ -18.81K$ -21.11K$ -30.41K$ -6.28K$ -21.83K
Operating Income
$ -18.81K$ -21.11K$ -30.41K$ -6.28K$ -21.83K
Other Income/Expenses
$ -2.00$ 2.00$ -3.00$ -3.00$ 0.00
Pretax Income
$ -18.81K$ -21.11K$ -30.41K$ -6.28K$ 0.00
Net Income
$ -18.81K$ -21.11K$ -30.41K$ -6.28K$ -21.83K
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Diluted EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Weighted Average Shares Outstanding
2.69B 2.69B 2.94B 2.94B 2.79B
Weighted Average Shares Outstanding (Diluted)
2.69B 2.69B 2.94B 2.94B 2.79B
Currency in USD

Lotus Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis